« Coronary Artery Plaque Imaging Device Cleared by FDA The U.S. | Main | FDA Approvals - Akorn-Strides, LLC Announces FDA The Approvals Of Two ANDAs For »

FDA Approves Relistor for Opioid-Induced Constipation The U.S. Food and


FDA Approves Relistor for Opioid-Induced Constipation
The U.S. Food and Drug Administration today approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.
 

©2006 FDA-News.com. All rights reserved.